WHO ICTRP trial
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients…
EUCTR2004-000963-81-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-000963-81-BE |
|---|---|
| Public title | A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines |
| Scientific title | A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines |
| Primary sponsor | Pierre Fabre Medicament |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): Therapeutic use (Phase IV): |
| Countries | Belgium;Austria |
| Conditions | Treatment in metastatic breast cancer previously treated with anthracyclines |
| Interventions | Trade Name: Navelbine Soft Capsules Product Name: Navelbine Soft Capsules Pharmaceutical Form: Capsule, soft INN or Proposed INN: Vinorelbine tartrate CAS Number: 125317-39-7 Concentration unit: mg milligram(s) Concentration type: range… |
| Registration date | Nov 7, 2005 |
| Target size | 230 |
| Secondary IDs | PM0259CA221B0;2004-000963-81-AT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: